Previous close | 1.8000 |
Open | 1.8000 |
Bid | 1.6800 x 4000 |
Ask | 1.7400 x 3000 |
Day's range | 1.6600 - 1.8100 |
52-week range | 0.2100 - 1.9000 |
Volume | |
Avg. volume | 4,472,829 |
Market cap | 1.027B |
Beta (5Y monthly) | 1.43 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Impressive quarterly performance with significant revenue growth and strategic advancements in radiopharmaceuticals.
Significant R&D Investments Lead to Increased Losses Despite Revenue Gains from Grants
PTC Therapeutics (PTCT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.